Continuous transdermal alcohol monitoring – the foundation of SCRAMx – has been confirmed by the scientific community, based on more than 70 years of research and 22 peer-reviewed studies. It is becoming an increasingly accepted and integral part of offender alcohol monitoring programs within courts, probation, treatment, and correctional agencies.
Transdermal monitoring has also been accepted in evidentiary hearings, and has been admissible in many court cases across the country.
